Photo of Thierry Facon from edimark.fr
Jun 24, 2024, 01:01
Thierry Facon discusses the groundbreaking IMRO study – Media Medic
Media Medic posted on LinkedIn:
” Exciting Highlights from the European Hematology Association (EHA) Conference!
We’re thrilled to share an exclusive interview with Dr. Thierry Facon, who discusses the groundbreaking IMRO study. This research sets the isatuximab VRD protocol as the new standard for elderly multiple myeloma patients ineligible for transplantation. Discover how this innovative treatment improves safety and quality of life, thanks to global collaboration, including key contributions from Chinese clinical doctors. Don’t miss these significant advancements in hematology!”
Source: Media Medic/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19
Dec 21, 2024, 19:18
Dec 21, 2024, 18:59
Dec 21, 2024, 18:57
Dec 21, 2024, 18:54